Search

Your search keyword '"Farb MG"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Farb MG" Remove constraint Author: "Farb MG"
28 results on '"Farb MG"'

Search Results

1. Cardiometabolic implications of adipose tissue aging.

2. Pericardial Adipose Tissue Thrombospondin-1 Associates With Antiangiogenesis in Ischemic Heart Disease.

3. Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study.

4. Systematic dissection, preservation, and multiomics in whole human and bovine hearts.

5. Association of Bariatric Surgery With Vascular Outcomes.

6. Perivascular Adipose Tissue Inflammation in Ischemic Heart Disease.

7. Fat-Specific Protein 27 Regulation of Vascular Function in Human Obesity.

8. Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity.

9. Activation of non-canonical WNT signaling in human visceral adipose tissue contributes to local and systemic inflammation.

10. Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy.

11. WNT5A regulates adipose tissue angiogenesis via antiangiogenic VEGF-A 165 b in obese humans.

12. WNT5A-JNK regulation of vascular insulin resistance in human obesity.

13. Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling.

14. Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling.

15. Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity.

16. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion.

17. Visceral adiposopathy: a vascular perspective.

18. Effect of Bariatric Weight Loss on the Adipose Lipolytic Transcriptome in Obese Humans.

19. Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity.

20. Insulin resistance: a key therapeutic target for cardiovascular risk reduction in obese patients?

21. Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity.

22. Insulin status and vascular responses to weight loss in obesity.

23. Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus.

24. B lymphocytes in human subcutaneous adipose crown-like structures.

25. Relation of depot-specific adipose inflammation to insulin resistance in human obesity.

26. Arteriolar function in visceral adipose tissue is impaired in human obesity.

27. The A2b adenosine receptor modulates glucose homeostasis and obesity.

28. Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity.

Catalog

Books, media, physical & digital resources